Search Results - "Eisses, Bertha"

Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer by Boers, Jorianne, Eisses, Bertha, Zwager, Mieke C, van Geel, Jasper J L, Bensch, Frederike, de Vries, Erik F J, Hospers, Geke A P, Glaudemans, Andor W J M, Brouwers, Adrienne H, den Dekker, Martijn A M, Elias, Sjoerd G, Kuip, Evelien J M, van Herpen, Carla M L, Jager, Agnes, van der Veldt, Astrid A M, Oprea-Lager, Daniela E, de Vries, Elisabeth G E, van der Vegt, Bert, Menke-van der Houven van Oordt, Willemien C, Schröder, Carolina P

“…In metastatic breast cancer (MBC), [ F]fluorodeoxyglucose positron emission tomography/computed tomography ([ F]FDG-PET/CT) can be used for staging. We…”
Get full text

Molecular Imaging in Cancer Drug Development by Waaijer, Stijn J H, Kok, Iris C, Eisses, Bertha, Schröder, Carolina P, Jalving, Mathilde, Brouwers, Adrienne H, Lub-de Hooge, Marjolijn N, de Vries, Elisabeth G E

“…Development of new oncology drugs has increased since the improved understanding of cancer's complex biology. The oncology field has become the top therapeutic…”
Get full text

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma by Verhoeff, Sarah R, Oosting, Sjoukje F, Elias, Sjoerd G, van Es, Suzanne C, Gerritse, Sophie L, Angus, Lindsay, Heskamp, Sandra, Desar, Ingrid M E, Menke-van der Houven van Oordt, C Willemien, van der Veldt, Astrid A M, Arens, Anne I J, Brouwers, Adrienne H, Eisses, Bertha, Mulders, Peter F A, Hoekstra, Otto S, Zwezerijnen, Gerben J C, van der Graaf, Winette T A, Aarntzen, Erik H J G, Oyen, Wim J G, van Herpen, Carla M L

“…Watchful waiting (WW) can be considered for patients with metastatic clear-cell renal cell carcinoma (mccRCC) with good or intermediate prognosis, especially…”
Get full text

Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer by Eisses, Bertha, van Geel, Jasper J L, Brouwers, Adrienne H, Bensch, Frederike, Elias, Sjoerd G, Kuip, Evelien J M, Jager, Agnes, van der Vegt, Bert, Lub-de Hooge, Marjolijn N, Emmering, Jasper, Arens, Anne I J, Zwezerijnen, Gerben J C, Vugts, Daniëlle J, Menke-van der Houven van Oordt, C Willemien, de Vries, Elisabeth G E, Schröder, Carolina P

“…Understanding which patients with human epidermal growth factor receptor 2 (HER2)-negative or -low metastatic breast cancer (MBC) benefit from HER2-targeted…”
Get full text

Reflections on a Research Clerkship Abroad by Eisses, Bertha, de Vries, Jakob, Chang, Shine

“…Eisses, de Vries and Chang assert that, in their experience, a successful research experience abroad requires skills in organization, time management, good…”
Get full text

Abstract PO2-13-03: Spatial HER2 heterogeneity on HER2-PET in HER2-low and negative disease: potential biomarker for antibody-drug conjugate effect by Schroder, Carolien, van Geel, Jasper, Eisses, Bertha, Brouwers, Adrienne, Elias, Sjoerd, Bensch, Frederike, Kuip, Evelien, Jager, Agnes, Glaudemans, Andor, van der Vegt, Bert, van Oordt, Willemien Menke-van der Houven, de Vries, Elisabeth

“…Abstract Background: Anti-HER2 antibody drug conjugates (ADCs) can assert an effect in part of patients with HER2-low breast cancer. In light of patient burden…”
Get full text

Correlation between Histopathological Prognostic Tumor Characteristics and [[sup.18]F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer by Boers, Jorianne, Eisses, Bertha, Zwager, Mieke C, van Geel, Jasper J. L, Bensch, Frederike, de Vries, Erik F. J, Hospers, Geke A. P, Glaudemans, Andor W. J. M, Brouwers, Adrienne H, den Dekker, Ma, Elias, Sjoerd G, Kuip, Evelien J. M, van Herpen, Carla M. L, Jager, Agnes, van der Veldt, Astrid A. M, Oprea-Lager, Daniela E, de Vries, Elisabeth G. E, van der Vegt, Bert, Menke-van der Houven van Oordt, Willemien C, Schröder, Carolina P

“…Background: In metastatic breast cancer (MBC), [[sup.18]F]fluorodeoxyglucose positron emission tomography/computed tomography ([[sup.18]F]FDG-PET/CT) can be…”
Get full text